During the past decade, Södra Älvsborgs Sjukhus conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Södra Älvsborgs Sjukhus" #1 sponsor was "Karolinska Institutet" with 3 trials, followed by "Sahlgrenska University Hospital, Sweden" with 3 trials sponsored, "German CLL Study Group" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "Uppsala University" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Södra Älvsborgs Sjukhus" #1 collaborator was "Karolinska University Hospital" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "The Swedish Research Council" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Södra Älvsborgs Sjukhus" are "Chronic Lymphocytic Leukemia" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Myocardial Infarction" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Acute Vestibular Syndrome" (1 trials). Many other conditions were trialed in "Södra Älvsborgs Sjukhus" in a lesser frequency.

Most popular intervention types in "Södra Älvsborgs Sjukhus" are "Drug" (14 trials), "Procedure" (5 trials), "Other" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (3 trials), "Rituximab" (3 trials), "Obinutuzumab" (2 trials), "Placebo" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Södra Älvsborgs Sjukhus" are 25 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Södra Älvsborgs Sjukhus". undefined are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Södra Älvsborgs Sjukhus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Södra Älvsborgs Sjukhus, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".